LLOYD A ROWLAND Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LLOYD A ROWLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LLOYD A ROWLAND. LLOYD A ROWLAND is Vice President & General in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr. V.P. and General Counsel in Xencor Inc ($XNCR) and General Counsel in CytomX Therapeutics, Inc. ($CTMX).
Latest Insider Trading Transactions of LLOYD A ROWLAND
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMLN, CTMX, XNCR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 7.85 | 125,000 | 981,250 | 125,000 | |
Feb 19 2020 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 7.13 | 100,000 | 713,000 | 100,000 | |
Jun 04 2019 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Grant | A | 8.21 | 1,812 | 14,878 | 11,791 | 10 K to 11.8 K (+18.16 %) |
Mar 05 2019 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Buy | P | 10.33 | 9,000 | 92,970 | 9,979 | 979 to 10 K (+919.31 %) |
Jan 29 2019 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 16.85 | 54,900 | 925,065 | 54,900 | |
Dec 06 2018 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Grant | A | 11.73 | 979 | 11,484 | 979 | 0 to 979 |
Jan 28 2016 | XNCR | Xencor Inc | ROWLAND LLOYD A | Sr. V.P. and Genera ... | Option Exercise | A | 12.51 | 20,000 | 250,200 | 20,000 | |
Dec 21 2015 | XNCR | Xencor Inc | ROWLAND LLOYD A | Sr. V.P. and Genera ... | Buy | J | 0.00 | 1,501 | 0 | 1,501 | 0 to 1.5 K |
Mar 20 2015 | XNCR | Xencor Inc | ROWLAND LLOYD A | Sr. V.P. and Genera ... | Option Exercise | A | 15.99 | 25,000 | 399,750 | 25,000 | |
Sep 08 2003 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Vice President & Ge ... | Option Exercise | M | 5.59 | 5,000 | 27,950 | 45,000 | |
Sep 08 2003 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Vice President & Ge ... | Sell | S | 28.65 | 5,000 | 143,250 | 5,104 | 10.1 K to 5.1 K (-49.49 %) |
Sep 08 2003 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Vice President & Ge ... | Buy | M | 5.59 | 5,000 | 27,950 | 10,104 | 5.1 K to 10.1 K (+97.96 %) |
Page: 1